Guy H. Montgomery
- ASSOCIATE PROFESSOR Oncological Sciences
- ASSOCIATE PROFESSOR Psychiatry
PHD, University of Connecticut
B.A, State University of New York at Binghamton
Major: Psychology | Minor: Economics
Memorial Sloan-Kettering Cancer Center (MSKCC)
Ph.D., University of Connecticut
Internship, Clinical Psychology
Manhattan Veterans Administration Medical Center
- Dr. Montgomery is Director of the Integrative Behavioral Medicine Program and Associate Professor in the Department of Oncological Sciences, Division of Cancer Prevention and Control at Mount Sinai School of Medicine in New York. Dr. Montgomery research is focused on developing, testing and disseminating psychological interventions to reduce suffering related to cancer and its treatment. To accomplish these goals, his work incorporates both clinical psychology and health economic perspectives.
Dr. Montgomery is a nationally recognized clinical psychologist. His early research focused on the role of response expectancies in the production of placebo effects. He has continued to pursue a program of research on the causal role of response expectancies in patients' experiences of side effects and symptoms associated with cancer and its treatment. His research has identified psychological predictors of response expectancies, the role of response expectancies in cancer-related pain, fatigue, nausea, and distress, and empirically validated cognitive-behavioral interventions (particularly hypnosis) to modify response expectancies, and thereby reduce aversive side effects.
Dr. Montgomery has ongoing clinical trials in breast cancer surgical patients and breast cancer radiation oncology patients. He is a past president of the Society for Psychological Hypnosis, and a Fellow of the American Psychological Association. He received his Ph.D. in clinical psychology from the University of Connecticut in 1995, completed a fellowship Psycho-oncology at Memorial Sloan-Kettering Cancer Center in 1997, and joined the faculty at Mount Sinai in 1998. He has published more than 50 empirical articles, and has received funding from the National Cancer Institute and the American Cancer Society.
Dr. Montgomery's research group focuses on the validation and translation of cognitive-behavioral interventions to improve quality of life in cancer patients. Included in this approach is establishing the clinical efficacy as well as cost-effectiveness to better encourage widespread adoption of these techniques.
Montgomery GH, Kirsch I. Mechanisms of placebo pain reduction: An empirical investigation. Psychological Science 1996 May; 7(3): 174.
Montgomery GH, Kirsch I. Classical conditioning and the placebo effect. Pain 1997 Aug; 72(1-2): 107-113.
Montgomery GH, Weltz CR, Seltz M, Bovbjerg DH. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002 Jan; 50(1): 17-32.
Montgomery GH, David D, Winkel G, Silverstein JH, Bovbjerg DH. The effectiveness of adjunctive hypnosis with surgical patients: A meta-analysis. Anesth Analg 2002 June; 94(6): 1639-1645.
Montgomery GH, Bovbjerg DH. Expectations of chemotherapy-related nausea: Emotional and experiential predictors. Ann Behav Med 2003; 25(1): 48-54.
Montgomery GH, Bovbjerg DH. Presurgery distress and specific response expectancies predict postsurgery outcomes in surgery patients confronting breast cancer. Health Psychol 2004 Jul; 23(4): 381-387.
Green JP, Barabasz AF, Barrett D, Montgomery GH. Forging ahead: the 2003 APA Division 30 definition of hypnosis. Int J Clin Exp Hypn 2005 Jul; 53(3): 259-264.
David D, Bovbjerg DH, Montgomery GH. Relations between coping responses and optimism?"pessimism in predicting anticipatory psychological distress in surgical breast cancer patients. Personality and Individual Differences 2006 Jan; 40(2): 203-213.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Montgomery did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 2nd Room 2-70
1425 Madison Avenue
New York, NY 10029